#  DRSC Director featured in Q&A 

 





January 07, 2020

 

 

 Learn about DRSC/TRiP activities focused on using CRISPR activation to develop human disease models in a recently published [Q&A with our Director](https://www.oxfordglobal.co.uk/wp-content/uploads/2019/12/Stephanie-Mohr-Spotlight.pdf), Dr. S.E. Mohr, who will be a speaker this spring at an upcoming genome editing conference in Boston, MA.

 Also of recent interest -- this [article in *Lab Animal* on CRISPR screens](https://rdcu.be/bZ0z7), which features discussion with *Drosophila* CRISPR pooled screen technology developer Dr. R. Viswanatha.



 

 

 



 

 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)